TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Army to run 84-bed L2 Covid facility at Rajindra Hospital

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Tribune News Service
Patiala, May 10

Advertisement

To assist in handling the pandemic situation at Government Rajindra Hospital, doctors and paramedics of Army will take over one of the floors of the Covid ward of the health facility. An Army team led by seven doctors will take over the second floor of super specialty building, which is a Covid ward of Rajindra Hospital, tomorrow morning.

Advertisement

Confirming the development, HS Rekhi, Medical Superintendent, said, Army doctors would run 84-bed L2 facility at Rajindra Hospital. He further added that the hospital would provide only infrastructure and medicines.

“They Army will bring their allied staff. We will have to provide just infrastructure and medicines,” he said.

Notably, Covid patient load at the hospital has increased manifold over the past few days.

Advertisement

Meanwhile, the daily death toll at the Covid isolation facility of the Government Rajindra Hospital continues to rise. Around 38 coronavirus patients, including four suspected, succumbed to the disease at the isolation wing of the hospital while only nine were discharged during the past 24 hours.

Of 38 patients, who succumbed to the disease, 12 were from Patiala and five from other states.

Advertisement
Show comments
Advertisement